No Picture
News

Little Conatus’ Novartis-partnered liver drug suffers third straight defeat, but CEO Mento is still holding out hope

Little Conatus? Novartis-partnered liver drug is one step closer to the scrap heap, with its third mid-stage failure.
The Swiss drugmaker handed the San Diego-based biotech $50 million upfront and an injection of confidence in late 2016 to license the … […]

No Picture
News

WARF Therapeutics announces partnership with Sanford Burnham Prebys Medical Discovery Institute

As part of its strategic initiative to bring new pharmaceuticals closer to patients, WARF Therapeutics announces a new partnership with Sanford Burnham Prebys Medical Discovery Institute (SBP). SBP is an independent, nonprofit institution dedicated to … […]

No Picture
Events

Drug Discovery Chemistry : Apr 08, 2019

Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. This year?s event will feature 800+ attendees, 180 speakers inclu… […]